Alaunos Therapeutics, Inc. (TCRT) Operating cash flow 2016–2025
Alaunos Therapeutics, Inc. (TCRT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.9MFY2025 · since FY2016: -$58.3M → -$2.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.9M | +42.3% |
| FY2024 | -$5.0M | +83.5% |
| FY2023 | -$30.1M | -3.1% |
| FY2022 | -$29.2M | +52.4% |
| FY2021 | -$61.5M | -7.8% |
| FY2020 | -$57.0M | -39.6% |
| FY2019 | -$40.9M | +17.4% |
| FY2018 | -$49.5M | +9.5% |
| FY2017 | -$54.7M | +6.3% |
| FY2016 | -$58.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice